Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126903811 | 12690381 | 1 | I | 201604 | 20160412 | 20160826 | 20160826 | PER | US-FRI-1000084013 | FOREST | 40.00 | YR | F | Y | 0.00000 | 20160826 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126903811 | 12690381 | 1 | PS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 10MG | Y | 21323 | 10 | MG | TABLET | QD | |||||
| 126903811 | 12690381 | 2 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 5MG | Y | 21323 | 5 | MG | TABLET | QD | |||||
| 126903811 | 12690381 | 3 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 7.5MG | Y | 21323 | 7.5 | MG | TABLET | QD | |||||
| 126903811 | 12690381 | 4 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 5MG | Y | 21323 | 5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126903811 | 12690381 | 1 | Eating disorder |
| 126903811 | 12690381 | 2 | Stress |
| 126903811 | 12690381 | 3 | Anxiety |
| 126903811 | 12690381 | 4 | Depression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126903811 | 12690381 | Anticholinergic syndrome | Anticholinergic syndrome |
| 126903811 | 12690381 | Anxiety | Anxiety |
| 126903811 | 12690381 | Confusional state | Confusional state |
| 126903811 | 12690381 | Drug withdrawal syndrome | |
| 126903811 | 12690381 | Flushing | Flushing |
| 126903811 | 12690381 | Headache | Headache |
| 126903811 | 12690381 | Hyperacusis | Hyperacusis |
| 126903811 | 12690381 | Insomnia | Insomnia |
| 126903811 | 12690381 | Intentional product misuse | |
| 126903811 | 12690381 | Nausea | Nausea |
| 126903811 | 12690381 | Off label use | |
| 126903811 | 12690381 | Pyrexia | Pyrexia |
| 126903811 | 12690381 | Tinnitus | Tinnitus |
| 126903811 | 12690381 | Visual impairment | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126903811 | 12690381 | 1 | 20160311 | 0 | ||
| 126903811 | 12690381 | 2 | 201604 | 201604 | 0 | |
| 126903811 | 12690381 | 3 | 201604 | 0 |